Dr. Harsh Amin, Chief Scientific Officer of Ivy Farm Technologies, is a stem cell scientist with a PhD from UCL and postdoctoral experience at Imperial College London. With nearly 20 publications, he has held leadership roles in start-ups and at Lonza Bioscience R&D, where he developed monoclonal antibody production platforms. Harsh excels in guiding teams through complex challenges, blending expertise in stem cell biology, tissue engineering, media and process development, and analytics. His dual perspective on scientific and commercial challenges makes him a key asset to Ivy Farm.